John G. Ullman & Associates’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-64,686
Closed -$2.5M 158
2020
Q4
$2.5M Sell
64,686
-1,225
-2% -$43.8K 0.39% 62
2020
Q3
$1.9M Buy
65,911
+16,934
+35% +$477K 0.39% 59
2020
Q2
$1.31M Sell
48,977
-7,600
-13% -$198K 0.32% 55
2020
Q1
$1.33M Buy
56,577
+5,365
+10% +$148K 0.35% 58
2019
Q4
$1.51M Buy
51,212
+2,921
+6% +$77.3K 0.26% 76
2019
Q3
$1.35M Buy
48,291
+28,174
+140% +$815K 0.25% 72
2019
Q2
$595K Buy
+20,117
New +$541K 0.1% 86

Other funds holding CTVA

John G. Ullman & Associates's CTVA Position: Q1 2021 in Review

John G. Ullman & Associates sold out of Corteva (CTVA) in Q1 2021, closing a stake of 64,686 shares — an estimated $2.5M sold.

John G. Ullman & Associates first reported a position in CTVA in Q2 2019 and held it in 7 quarters. The position peaked at $2.5M in Q4 2020. 1,078 funds tracked by Wall St. Rank hold CTVA as of Q1 2021.

  • John G. Ullman & Associates reported no remaining Corteva position as of Q1 2021 after selling out during the quarter.
  • John G. Ullman & Associates sold 64,686 Corteva shares in Q1 2021, an estimated $2.5M.
  • John G. Ullman & Associates first reported a position in Corteva in Q2 2019 and held it in 7 quarters.
  • John G. Ullman & Associates's Corteva position peaked at $2.5M in Q4 2020.
  • 1,078 funds tracked by Wall St. Rank held Corteva as of Q1 2021.

Based on John G. Ullman & Associates's 13F filing for Q1 2021, filed 22 Apr 2021.